Abnormal metabolic brain networks in a nonhuman primate model of parkinsonism

Journal of Cerebral Blood Flow and Metabolism

Volumn 32, Issue 4, 2012, Pages 633-642

  Ma, Yilong ^a   Peng, Shichun ^a   Spetsieris, Phoebe G ^a   Sossi, Vesna ^b   Eidelberg, David ^a   Doudet, Doris J ^b  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Animal models; brain imaging; glucose; Parkinson's disease; positron emission tomography

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; FLUORODEOXYGLUCOSE F 18;

ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLOBUS PALLIDUS; MACACA; MALE; METABOLISM; NONHUMAN; PARKINSONISM; PONS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RATING SCALE; SENSORIMOTOR CORTEX; THALAMUS; TOPOGRAPHY; VALIDATION PROCESS;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANIMALS; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; FEMALE; HUMANS; MACACA; MALE; PARKINSONIAN DISORDERS; PUTAMEN; THALAMUS;

EID: 84859421833     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2011.166     Document Type: Article

References (30)

1. Asanuma K, Tang C, Ma Y, Dhawan V, Mattis P, Edwards C, Kaplitt MG, Feigin A, Eidelberg D (2006) Network modulation in the treatment of Parkinson's disease. Brain 129:2667-78 (Pubitemid 44522100)
2. Black KJ, Koller JM, Snyder AZ, Perlmutter JS (2001) Template images for nonhuman primate neuroimaging: 2. Macaque. Neuroimage 14:744-8 (Pubitemid 32801720)
3. Blaizot X, Landeau B, Baron JC, Chavoix C (2000) Mapping the visual recognition memory network with PET in the behaving baboon. J Cereb Blood Flow Metab 20:213-9 (Pubitemid 30108438)
4. Brownell AL, Canales K, Chen YI, Jenkins BG, Owen C, Livni E, Yu M, Cicchetti F, Sanchez-Pernaute R, Isacson O (2003) Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson0s disease model. Neuroimage 20:1064-75 (Pubitemid 37268125)
5. Carlson JD, Pearlstein RD, Buchholz J, Iacono RP, Maeda G (1999) Regional metabolic changes in the pedunculopontine nucleus of unilateral 6-hydroxydopamine Parkinson0s model rats. Brain Res 828:12-9 (Pubitemid 29236470)
6. de Jong HW, van Velden FH, Kloet RW, Buijs FL, Boellaard R, Lammertsma AA (2007) Performance evaluation of the ECAT HRRT: an LSO-LYSO double layer high resolution, high sensitivity scanner. Phys Med Biol 52:1505-26 (Pubitemid 46646401)
7. Doudet DJ, Chan GL, Holden JE, McGeer EG, Aigner TA, Wyatt RJ, Ruth TJ (1998) 6-[18F]Fluoro-L-DOPA PET studies of the turnover of dopamine in MPTP-induced parkinsonism in monkeys. Synapse 29:225-32 (Pubitemid 28267931)
8. Doudet DJ, Cornfeldt ML, Honey CR, Schweikert AW, Allen RC (2004) PET imaging of implanted human retinal pigment epithelial cells in the MPTP-induced primate model of Parkinson0s disease. Exp Neurol 189:361-8 (Pubitemid 39221828)
9. Eidelberg D (2009) Metabolic brain networks in neurodegenerative disorders: a functional imaging approach. Trends Neurosci 32:548-57
10. Emborg ME, Carbon M, Holden JE, During MJ, Ma Y, Tang C, Moirano J, Fitzsimons H, Roitberg BZ, Tuccar E, Roberts A, Kaplitt MG, Eidelberg D (2007) Subthalamic glutamic acid decarboxylase gene therapy: changes in motor function and cortical metabolism. J Cereb Blood Flow Metab 27:501-9
11. Feigin A, Fukuda M, Dhawan V, Przedborski S, Jackson-Lewis V, Mentis MJ, Moeller JR, Eidelberg D (2001) Metabolic correlates of levodopa response in Parkinson's disease. Neurology 57:2083-8 (Pubitemid 33126878)
12. Guigoni C, Li Q, Aubert I, Dovero S, Bioulac BH, Bloch B, Crossman AR, Gross CE, Bezard E (2005) Involvement of sensorimotor, limbic, and associative basal ganglia domains in L-3,4-dihydroxyphenylalanine-induced dyskinesia. J Neurosci 25:2102-7 (Pubitemid 40289415)
13. Habeck C, Krakauer JW, Ghez C, Sackeim HA, Eidelberg D, Stern Y, Moeller JR (2005) A new approach to spatial covariance modeling of functional brain imaging data: ordinal trend analysis. Neural Comput 17:1602-45 (Pubitemid 40669913)
14. Habeck C, Stern Y (2010) Multivariate data analysis for neuroimaging data: overview and application to Alzheimer's disease. Cell Biochem Biophys 58:53-67
15. Hirano S, Asanuma K, Ma Y, Tang C, Feigin A, Dhawan V, Carbon M, Eidelberg D (2008) Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson0s disease. J Neurosci 28:4201-9
16. Huang C, Tang C, Feigin A, Lesser M, Ma Y, Pourfar M, Dhawan V, Eidelberg D (2007) Changes in network activity with the progression of Parkinson's disease. Brain 130:1834-46 (Pubitemid 47343798)
17. Ma Y, Eidelberg D (2007) Functional imaging of cerebral blood flow and glucose metabolism in Parkinson0s disease and Huntington's disease. Mol Imaging Biol 9:223-33 (Pubitemid 47028738)
18. Ma Y, Huang C, Dyke JP, Pan H, Alsop D, Feigin A, Eidelberg D (2010) Parkinson's disease spatial covariance pattern: noninvasive quantification with perfusion MRI. J Cereb Blood Flow Metab 30:505-9
19. Ma Y, Peng S, Flores J, Cornfeldt M,Mitrovic B, Eidelberg D, Doudet DJ (2008) Abnormal metabolic brain network in parkinsonian macaques: Modulation by retinal pigment epithelial (RPE) cell implantation. Neurology 71:154-5
20. Ma Y, Tang C, Spetsieris PG, Dhawan V, Eidelberg D (2007) Abnormal metabolic network activity in Parkinson's disease: test-retest reproducibility. J Cereb Blood Flow Metab 27:597-605
21. Martin R, Browden D (2000) Primate brain maps: structure of the macaque brain. Amsterdam, The Netherlands: Elsevier Martinez ZA
22. Colgan M, Baxter Jr LR, Quintana J, Siegel S, Chatziioannou A, Cherry SR, Mazziotta JC, Phelps ME (1997) Oral 18F-fluoro-2-deoxyglucose for primate PET studies without behavioral restraint: demonstration of principle. Am J Primatol 42:215-24 (Pubitemid 27288686)
23. Mattis PJ, Tang CC, Ma Y, Dhawan V, Eidelberg D (2011) Network correlates of the cognitive response to levodopa in Parkinson disease. Neurology 77:858-65
24. Mitchell IJ, Clarke CE, Boyce S, Robertson RG, Peggs D, Sambrook MA, Crossman AR (1989) Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1-methyl-4-phenyl-1,2, 3,6-tetrahydropyridine. Neuroscience 32:213-26 (Pubitemid 19284718)
25. Moeller JR, Habeck C (2006) Reciprocal benefits of massunivariate and multivariate modeling in brain mapping: applications to event-related functional MRI, H215O-, and FDG-PET. Int J Biomed Imaging 2006:1-13
26. Moeller JR, Nakamura T, Mentis MJ, Dhawan V, Spetsieres P, Antonini A, Missimer J, Leenders KL, Eidelberg D (1999) Reproducibility of regional metabolic covariance patterns: comparison of four populations. J Nucl Med 40:1264-9 (Pubitemid 29385633)
27. Rauchs G, Blaizot X, Giffard C, Baron JC, Insausti R, Chavoix C (2006) Imaging visual recognition memory network by PET in the baboon: perirhinal cortex heterogeneity and plasticity after perirhinal lesion. J Cereb Blood Flow Metab 26:301-9
28. Snow BJ, Vingerhoets FJ, Langston JW, Tetrud JW, Sossi V, Calne DB (2000) Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism. J Neurol Neurosurg Psychiatry 68:313-6 (Pubitemid 30248704)
29. Spetsieris PG, Eidelberg D (2011) Scaled subprofile modeling of resting state imaging data in Parkinson's disease: methodological issues. Neuroimage 54:2899-914
30. Tang CC, Poston KL, Dhawan V, Eidelberg D (2010) Abnormalities in metabolic network activity precede the onset of motor symptoms in Parkinson's disease. J Neurosci 30:1049-56